Coronary heart disease
Conditions
Interventions
Dyspnea Group:None
Sponsors
Chinese Academy of Medical Sciences Peking Union Medical College TEDA International Cardiovascular Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients aged >= 18 years with coronary heart disease who were hospitalized in our hospital and treated with ticagrelor from January 2019 to January 2025 were enrolled;
Exclusion criteria
Exclusion criteria: 1.With a history of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), bronchial asthma, pulmonary embolism, acute respiratory distress syndrome (ARDS), etc. 2.Cardiac insufficiency [left ventricular ejection fraction (LVEF) < 40% or New York Heart Association (NYHA) functional classification grade ? or above]; 3.Severe hepatic and renal dysfunction [Child-Pugh classification grade C, estimated glomerular filtration rate (eGFR) < 30 mL/(min•1.73 m²)]; 4.Active peptic ulcer or gastrointestinal bleeding; 5.A history of hemorrhagic stroke within the past 6 months;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whether dyspnea occurred; | — |
Countries
China
Contacts
Public ContactRuihua Wang
Chinese Academy of Medical Sciences Peking Union Medical College TEDA International Cardiovascular Hospital
Outcome results
None listed